3

PRIMARY DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: March 25, 2011
Period of Report: February 7, 2011
Accession Number: 0001513160-11-000012

View Document ↗ View on SEC.gov ↗